Gabrielle Baccarin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gabrielle Baccarin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adolfo Moraes de Souza
School of Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
1 shared publication - Bernardo Savaya Lima
Pontifícia Universidade Católica de São Paulo, São Paulo SP, Brazil
1 shared publication - Danilo de Assis Pereira
Pontifícia Universidade Católica de São Paulo, São Paulo SP, Brazil
1 shared publication - Fabiano Reis
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Radiologia e Oncologia, Campinas SP, Brazil
1 shared publication - Gustavo Kazuo Yamada
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas SP, Brazil
1 shared publication - Juliana Ávila Duarte
Hospital de Clínicas de Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-014
Magnetic resonance imaging in leukodystrophies: characteristic patterns and diagnostic relevance
Leukodystrophies are inherited disorders that primarily affect the central nervous system white matter and often present with nonspecific symptoms, making early diagnosis difficult. Magnetic resonance imaging (MRI) is the key initial imaging test because it reveals characteristic myelin patterns that can guide biochemical and genetic workups. To review clinically useful MRI and MR spectroscopy (MRS) patterns in major leukodystrophies and emphasize their diagnostic relevance using a practical, pattern-recognition approach. Narrative review of the literature integrating conventional MRI, including T1/T2 fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI), as well as advanced techniques (MRS), with a pictorial, case-based approach. The pivotal imaging distinction is between hypomyelination—diffuse, persistent T2/FLAIR hyperintensity with relative temporal stability and absent enhancement—and demyelination, characterized by confluent, progressive lesions with disorder-specific topographic predilection. Recognizable signatures include U-fiber sparing and a tigroid pattern in metachromatic leukodystrophy (MLD); parieto-occipital predominance with trizonal enhancement and restricted diffusion in X-linked adrenoleukodystrophy (X-ALD); frontal predominance and the “tadpole sign” in Alexander's disease; optic pathway and thalamic involvement in Krabbe's disease; markedly elevated N-acetylaspartate (NAA) on MRS in Canavan's disease; and tract-selective leukoencephalopathy brainstem/spinal cord involvement with a lactate peak (LBSL). These imaging clues refine differential diagnosis, guide targeted genetic testing, and support longitudinal monitoring. The use of MRI—especially when complemented by DWI and MRS—remains central for early recognition and classification of leukodystrophies. A structured, pattern-based approach integrating clinical context with imaging topography can reduce diagnostic delay and support timely management.
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-014
Open AccessMagnetic resonance imaging in leukodystrophies: characteristic patterns and diagnostic relevance
Leukodystrophies are inherited disorders that primarily affect the central nervous system white matter and often present with nonspecific symptoms, making early diagnosis difficult. Magnetic resonance imaging (MRI) is the key initial imaging test because it reveals characteristic myelin patterns that can guide biochemical and genetic workups. To review clinically useful MRI and MR spectroscopy (MRS) patterns in major leukodystrophies and emphasize their diagnostic relevance using a practical, pattern-recognition approach. Narrative review of the literature integrating conventional MRI, including T1/T2 fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI), as well as advanced techniques (MRS), with a pictorial, case-based approach. The pivotal imaging distinction is between hypomyelination—diffuse, persistent T2/FLAIR hyperintensity with relative temporal stability and absent enhancement—and demyelination, characterized by confluent, progressive lesions with disorder-specific topographic predilection. Recognizable signatures include U-fiber sparing and a tigroid pattern in metachromatic leukodystrophy (MLD); parieto-occipital predominance with trizonal enhancement and restricted diffusion in X-linked adrenoleukodystrophy (X-ALD); frontal predominance and the “tadpole sign” in Alexander's disease; optic pathway and thalamic involvement in Krabbe's disease; markedly elevated N-acetylaspartate (NAA) on MRS in Canavan's disease; and tract-selective leukoencephalopathy brainstem/spinal cord involvement with a lactate peak (LBSL). These imaging clues refine differential diagnosis, guide targeted genetic testing, and support longitudinal monitoring. The use of MRI—especially when complemented by DWI and MRS—remains central for early recognition and classification of leukodystrophies. A structured, pattern-based approach integrating clinical context with imaging topography can reduce diagnostic delay and support timely management.